Cardinal Health, Inc. announced on October 1, 2026, that it has entered into a binding Letter of Intent to extend its pharmaceutical distribution agreements with CVS Health. The extension is set to continue through June 30, 2032, maintaining the current scope of distribution services.
Company leadership emphasized the value of the long-standing partnership. Jason Hollar, Chief Executive Officer of Cardinal Health, stated, “We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers.”
In conjunction with the announcement, Cardinal Health reaffirmed its financial outlook. The company confirmed its fiscal year 2027 non-GAAP earnings per share (EPS) guidance range of $12.40 to $12.60. Additionally, the company reiterated its long-term non-GAAP EPS growth range guidance of 12% to 14%.
Further updates regarding the agreement and financial performance may be provided during the company’s first quarter earnings call scheduled for November 5, 2026.
